Abstract
Pediatric obesity is a growing health problem, with a current prevalence of 18.5% in the United States. Obesity is associated with a variety of physiologic abnormalities, including hyperlipidemia, hypertension, and insulin resistance, which together contribute to the metabolic syndrome. Metabolic derangements are known to be primary contributors to the early mortality experienced by patients with severe mental illness. Various commonly used mental health medications are associated with weight gain and metabolic abnormalities. Evaluating the risk vs benefit of these medications and intervening to minimize these risks remains a challenge for many child and adolescent psychiatrists.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call